MAPT and Alzheimer disease: Compared with unaffected control individuals, neurons derived from both familial and sporadic patients exhibit significantly increasing pathological markers of Alzheimer’s disease, which are amyoid-β (1–40), phospho-tau (Thr231) and active glycogen synthase kinase (aGSK-3β) and RAB5-positive early endosomes, respectively [89].